CNN (12/14, Howard) reports, “The first oral pill approved in the United States to treat postpartum depression is now available by prescription, according to the drugmakers.” The therapy, called Zurzuvae (zuranolone), which was approved by the FDA in August and “is now at specialty pharmacies, can also be shipped directly to patients, Biogen and Sage Therapeutics Inc. said in an announcement Thursday.” Notably, “the medication will cost $15,900 per course before insurance, raising some concerns about how many people will be able to access it.”
Related Links:
— “First postpartum depression pill now available in the US, drugmakers say,” Jacqueline Howard, CNN, December 14, 2023